| http://www.w3.org/ns/prov#value | - The end result is a crippling of the ability of the immune cell to over react.These new drugs hold the hope for efficacy and safety similar to biologics with the convenience of aonce or twice daily pill.Pfizer's JAK inhibitor tofacitinib is the most advanced.
|
